Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations

Journal of Pharmacology and Experimental Therapeutics

Volumn 329, Issue 3, 2009, Pages 1040-1047

  Saurer, Timothy B ^a   Ijames, Stephanie G ^a   Lysle, Donald T ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CONCANAVALIN A; DIAMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE STATUS; IMMUNOMODULATION; LEWIS RAT; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; BENZAZEPINES; CELL PROLIFERATION; CONCANAVALIN A; CYTOTOXICITY, IMMUNOLOGIC; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEROIN; IMMUNE SYSTEM; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LIVER; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NUCLEUS ACCUMBENS; RATS; RATS, INBRED LEW; RECEPTORS, DOPAMINE D1; SPLEEN;

EID: 66749110023     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.148627     Document Type: Article

References (40)

1. Deleplanque B, Vitiello S, Le Moal M, and Neveu PJ (1994) Modulation of immune reactivity by unilateral striatal and mesolimbic dopaminergic lesions. Neurosci Lett 166:216-220.
2. Devoino L, Alperina E, Galkina O, and Ilyutchenok R (1997) Involvement of brain dopaminergic structures in neuroimmunomodulation. Int J Neurosci 91:213-228.
3. El Solh AA, Bhora M, Pineda L, and Dhillon R (2006) Nosocomial pneumonia in elderly patients following cardiac surgery. Respir Med 100:729-736.
4. Fecho K, Dykstra LA, and Lysle DT (1993) Evidence for β-adrenergic-receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 265:1079-1087.
5. Fecho K, Maslonek KA, Dykstra LA, and Lysle DT (1996) Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 277:633-645.
6. Fecho K, Nelson CJ, and Lysle DT (2000) Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment. Immunopharmacology 46:193-207.
7. Fuchs BA and Pruett SB (1993) Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J Pharmacol Exp Ther 266:417-423.
8. Gomez-Flores R, Suo JL, and Weber RJ (1999) Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav Immun 13:212-224.
9. Govitrapong P, Suttitum T, Kotchabhakdi N, and Uneklabh T (1998) Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 286:883-889.
10. Heimer L, Zahm DS, Churchill L, Kalivas PW, and Wohltmann C (1991) Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41:89-125.
11. Hernandez MC, Flores LR, and Bayer BM (1993) Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther 267:1336-1341.
12. Irwin M, Hauger RL, Jones L, Provencio M, and Britton KT (1990) Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 255:101-107.
13. Iuvone T, Capasso A, D'Acquisto F, and Carnuccio R (1995) Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun 212:975-980.
14. Kaiko RF, Wallenstein SL, Rogers AG, Grabinski PY, and Houde RW (1981) Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med 304:1501-1505.
15. Katafuchi T, Ichijo T, Take S, and Hori T (1993) Hypothalamic modulation of splenic natural killer cell activity in rats. J Physiol 471:209-221.
16. Lanier RK, Ijames SG, Carrigan KA, Carelli RM, and Lysle DT (2002) Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug Alcohol Depend 66:225-233.
17. Lockwood LL, Silbert LH, Fleshner M, Laudenslager ML, Watkins LR, and Maier SF (1994) Morphine-induced decreases in in vivo antibody responses. Brain Behav Immun 8:24-36.
18. Louria DB, Hensle T, and Rose J (1967) The major medical complications of heroin addiction. Ann Intern Med 67:1-22.
19. Lysle DT and How T (2000) Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology 46:181-192.
20. Lysle DT, Coussons ME, Watts VJ, Bennett EH, and Dykstra LA (1993) Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 265:1071-1078.
21. Lysle DT, Hoffman KE, and Dykstra LA (1996) Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther 277:1533-1540.
22. Martin WR and Fraser HF (1961) A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther 133:388-399.
23. Martucci C, Franchi S, Lattuada D, Panerai AE, and Sacerdote P (2007) Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes. J Leukoc Biol 81:344-354.
24. Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, Greenberg AH, and Nance DM (2004) Stress-induced suppression of in vivo splenic cytokine production in the rat by neural and hormonal mechanisms. Brain Behav Immun 18:262-273.
25. Oldendorf WH, Hyman S, Braun L, and Oldendorf SZ (1972) Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 178:984-986.
26. Peterson PK, Sharp B, Gekker G, Brummitt C, and Keane WF (1987) Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest 80:824-831.
27. Pontieri FE, Tanda G, and Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A 92:12304-12308.
28. Rady JJ, Roerig SC, and Fujimoto JM (1991) Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J Pharmacol Exp Ther 256:448-457.
29. Rossi GC, Brown GP, Leventhal L, Yang K, and Pasternak GW (1996) Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia. Neurosci Lett 216:1-4.
30. Rougé-Pont F, Piazza PV, Kharouby M, Le Moal M, and Simon H (1993) Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study. Brain Res 602:169-174.
31. Saurer TB, Carrigan KA, Ijames SG, and Lysle DT (2006a) Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol 173:3-11.
32. Saurer TB, Ijames SG, and Lysle DT (2006b) Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 177:18-26.
33. Schwacha MG, McGwin G Jr, Hutchinson CB, Cross JM, Maclennan PA, and Rue LW 3rd (2006) The contribution of opiate analgesics to the development of infectious complications in burn patients. Am J Surg 192:82-86.
34. Shavit Y, Lewis JW, Terman GW, Gale RP, and Liebeskind JC (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188-190.
35. Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki N, and Gibbons N (1998) Morphine enhances macrophage apoptosis. J Immunol 160:1886-1893.
36. Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW, and Rogers TJ (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267:703-706.
37. Tseng RJ, Padgett DA, Dhabhar FS, Engler H, and Sheridan JF (2005) Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behav Immun 19:153-164.
38. Weber RJ and Pert A (1989) The periaqueductal gray-matter mediates opiate-induced immunosuppression. Science 245:188-190.
39. Wenner M, Kawamura N, Miyazawa H, Ago Y, Ishikawa T, and Yamamoto H (1996) Acute electrical stimulation of lateral hypothalamus increases natural killer cell activity in rats. J Neuroimmunol 67:67-70.
40. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, and Guyre PM (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83:500-508.